相关实验视频
Updated: Jan 13, 2026
16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
36.0K
在特殊患者群体中进行心脏移植
Kathryn R Armstrong1, Anne I Dipchand2
1Heart Centre, British Columbia Children's Hospital, 4480 Oak Street, Vancouver, Canada, V6H3N1.
JHLT open
|October 28, 2025
概括
在特殊人群中进行心脏移植 (HTx) 需要仔细考虑医疗,发育和心理社会因素. 评估这些方面可以确保为患有遗传病,肌肉病和智力迟缓的儿童提供最佳的结果和生活质量.
科学领域:
- 儿童心脏病学 儿童心脏病学
- 移植手术 移植手术
- 遗传学 遗传学 是一个
背景情况:
- 对于患有末期心力衰竭的儿科患者,心脏移植 (HTx) 越来越多地被考虑.
- 特殊的患者群体,包括患有遗传病,肌肉病,线粒体疾病,结缔组织疾病 (CTD) 和智力发育迟缓的患者,对HTx构成独特的挑战.
- 确定儿童的最佳利益,包括医疗,身体,情感,发育和心理社会方面,至关重要.
研究的目的:
- 在特殊的儿科患者群体中审查HTx的指示.
- 探索这些患者的结局和生存率.
- 突出评估适合性和优化移植后护理的关键考虑因素.
主要方法:
- 文献综述,重点关注患有特定潜在疾病的儿科患者的心脏移植.
- 对现有结果,存活率和并发症数据的分析.
- 讨论与ISHLT指南一致的多学科评估原则.
主要成果:
- 对这些人群的HTx评估需要对心肺状况,并发症和心理社会因素进行全面评估.
- 特定的疾病,如线粒体疾病和努南综合征可能会带来独特的风险,包括加速疾病进展或增加移植后并发症.
- 需要进一步的研究才能充分理解这些复杂案件的长期结果.
结论:
- 整体的,以患者为中心的方法对于患有复杂潜在疾病的儿童进行心脏移植至关重要.
- 精心的移植前评估和持续监测对于最大限度地提高存活率和生活质量至关重要.
- 解决与遗传疾病,肌病,CTD和智力延迟相关的特定风险对于成功的HTx结果至关重要.
相关概念视频
01:28Kidney Transplant I: Introduction
333
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
333
01:29Cardiomyopathy V: Interprofessional Care
331
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
331
01:22Heart Failure VI: Adjunct Therapies
246
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
246
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
393
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
393
01:30Cardiomyopathy II: Dilated Cardiomyopathy
457
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
457